Stockreport

Lyra Therapeutics raises $56 million in IPO, priced at high end of range [MarketWatch]

Lyra Therapeutics, Inc.  (LYRA) 
PDF Lyra Therapeutics Inc. , a biotech specializing in treatments for ear, nose and throat diseases, priced its initial public offering late Thursday at $16 a share, the hig [Read more]